Oscar Soto-Angona
Overview
    Explore the profile of Oscar Soto-Angona including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              7
            
            
              Citations
              71
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Sabucedo P, Andion O, Neimeyer R, Soto-Angona O, Javkin J, Haro J, et al.
  
  
    Front Psychiatry
    . 2025 Jan;
          15():1484736.
    
    PMID: 39839135
  
  
          Background: Psychotherapy for Prolonged Grief Disorder (PGD), a condition characterized by an intense and persistent grief response, has received increased attention over the past decades. Evidence-based approaches to prevent PGD...
      
2.
        
    
    Soto-Angona O, Fortea A, Fortea L, Martinez-Ramirez M, Santamarina E, Lopez F, et al.
  
  
    Eur Neuropsychopharmacol
    . 2024 Jun;
          85:35-42.
    
    PMID: 38917636
  
  
          Seizures are a concerning adverse event frequently associated with the use of psychedelics, and hence, studies involving these substances tend to exclude patients with past history of epilepsy. This is...
      
3.
        
    
    Gargot T, Kisand H, Miguel A, Tanyeri S, Soron T, Serene B, et al.
  
  
    Eur J Trauma Dissociation
    . 2024 Apr;
          5(2):100193.
    
    PMID: 38620807
  
  
          Most of the recent studies indicated the prevalence of Post-Traumatic Stress Symptoms (PTSS) are increasing after the COVID pandemic around the world. Bo et al. reported PTSS prevalence of 96.2%...
      
4.
        
    
    Vendrell-Serres J, Soto-Angona O, Rodriguez-Urrutia A, Inzoli B, Gonzalez A, Ramos-Quiroga J
  
  
    Clin Psychopharmacol Neurosci
    . 2024 Jan;
          22(1):159-168.
    
    PMID: 38247422
  
  
          Objective: : Treatment Resistant Depression (TRD) is commonly defined as the lack of response to two or more anti-depressants with different mechanisms of action. Up to 30% of patients diagnosed...
      
5.
        
    
    Ferrer M, Soto-Angona O, Soler-Artigas M, Ibanez P, Fadeuilhe C, Palma-Alvarez R, et al.
  
  
    Clin Psychopharmacol Neurosci
    . 2022 Jul;
          20(3):482-490.
    
    PMID: 35879032
  
  
          Objective: Agitation in patients diagnosed with personality disorders (PD) is one of the most frequent crises in emergency departments (ED). Although many medications have been tested, their effectiveness has been...
      
6.
        
    
    Vendrell-Serres J, Soto-Angona O, Rodriguez-Urrutia A, Arteaga-Henriquez G, Ramos-Quiroga J
  
  
    Ther Adv Psychopharmacol
    . 2021 Jun;
          11:20451253211022187.
    
    PMID: 34188796
  
  
          Functional neurological disorder (FND) is a complex neuropsychiatric condition characterized by the presence of neurological symptoms and signs (either motor or sensory) that cannot be explained by any known medical...
      
7.
        
    
    Anmella G, Fico G, Lotfaliany M, Hidalgo-Mazzei D, Soto-Angona O, Gimenez-Palomo A, et al.
  
  
    Neurosci Biobehav Rev
    . 2021 Apr;
          126:529-541.
    
    PMID: 33831461
  
  
          We examined bipolar disorder (BD) as a risk factor for developing cancer and the role of lithium on cancer incidence. We conducted two systematic review and meta-analyses of population-based studies...
      
8.
        
    
    Soto-Angona O, Anmella G, Valdes-Florido M, De Uribe-Viloria N, Carvalho A, Penninx B, et al.
  
  
    BMC Med
    . 2020 Oct;
          18(1):261.
    
    PMID: 32998725
  
  
          Background: Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis in over 5% of the parenchyma in the absence of excessive alcohol consumption. It is more prevalent in patients...